No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA — Belgian biopharmaceutical company UCB and American pharmaceutical giant Eli Lilly have led a US$52 million funding round for RNA biotech startup Switch Therapeutics for its conditionally activated siRNA…
Read More
USA — Senator Bernie Sanders, Chair of the Senate Health Committee, has introduced a new bill alongside a companion bill in the House that aims to set the price of…
Read More
USA — Eli Lilly is set to reduce insulin prices and expand cost cap for insured patients, offering relief to those with diabetes who have to pay high annual costs…
Read More
USA — The US Food and Drug Administration (FDA) has approved Eli Lilly and Co.’s drug (pirtobrutinib) for the treatment of a rare form of blood cancer. The indication aims…
Read More
USA — Eli Lilly has announced that it will invest US$450 million in a North Carolina manufacturing plant to meet the rising demand for its diabetes drugs Mounjaro and Trulicity.…
Read More
UK — AbbVie and Eli Lilly and Company (Lilly) have shocked the UK Government by withdrawing from the voluntary medicines pricing agreement in response to increasingly harsh revenue clawbacks. The…
Read More
USA — Eli Lilly and Co. has decided to end its joint project with Ypsomed to enter the US insulin pump market and instead focus on its diabetes offerings. In…
Read More
INDIA —Eli Lilly and Company (India) Pvt. Ltd. has announced the introduction of the new indication for Ramiven (abemaciclib), a product to treat early stage breast cancer following approval from…
Read More
USA — TheU.S Food and Drug Administration (FDA) has designated Eli Lilly’s Rezvoglar as “interchangeable” with Sanofi’s Lantus, making it the second insulin biosimilar to receive the prestigious designation. Rezvoglar…
Read More
USA — Eli Lilly and Company is set to acquire Akouos, a developer of viral gene therapies for the treatment of inner ear conditions, including sensorineural hearing loss as the…
Read More